. Author manuscript; available in PMC: 2017 Dec 1.

Published in final edited form as: Cancer Metastasis Rev. 2016 Dec;35(4):677–684. doi: 10.1007/s10555-016-9638-9

Table 3.

Public datasets related to brain metastasis

Accession	Description
GSE14020	Affymetrix microarray profiling of distinct organ-specific metastatic tumors (brain, bone, lung and liver) of breast cancer patients.
GSE12276	Affymetrix microarray profiling of primary breast cancer tumors with clinical follow-up of brain or other metastatic relapse and survival.
GSE2603	Affymetrix microarray profiling of MDA-MB-231 sublines of different metastatic tropisms (bone and lung) and primary breast cancer tumors with metastasis follow-up.
GSE2034	Affymetrix microarray profiling of primary human breast cancer tumors with brain metastasis follow-up information.
GSE3141	Affymetrix microarray profiling of primary lung cancer specimens with clinical follow-up data of brain metastasis-free survival time.
GSE14690	Illumina DASL (the cDNA-mediated Annealing, Selection, extension and Ligation) cancer panel profiling of matched and unmatched breast cancer primary tumor and brain metastasis.
GSE20016	NHGRI (National Human Genome Research Institute) cDNA array profiling of laser-captured epithelial cells from resected human brain metastases and unmatched primary breast tumors.
GSE38057	Illumina DASL cancer panel of primary HER2+ breast tumors with or without brain metastasis relapse.
GSE19184	Illumina human and mouse beadchip profiling of 4 different types of cancer (MDA-MB-231Br3, PC14Br4, KM12M, A375SM) experimental brain metastases and orthotopic xenografts in mice.